Feng Sun
researcher (ORCID 0000-0003-4334-6805)
Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: a pairwise and network meta-analysis.Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysisEffects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysisEfficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisEfficacy and Safety of Anti-cancer Biosimilars Compared to Reference Biologics in Oncology: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsEfficacy and Safety of Supportive Care Biosimilars Among Cancer Patients: A Systematic Review and Meta-AnalysisGastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysisImpact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisInterventions for treating gas gangreneLeptin and coronary heart disease: a systematic review and meta-analysis.Protein requirements in healthy adults: a meta-analysis of nitrogen balance studiesThe effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review
author
Feng Sun
researcher (ORCID 0000-0003-4334-6805)
worksFor
type
comment
ikertzailea
@eu
onderzoeker
@nl
researcher (ORCID 0000-0003-4334-6805)
@en
հետազոտող
@hy
研究者
@ja
研究者
@zh
연구원
@ko
label
Feng Sun
@ast
Feng Sun
@en
Feng Sun
@es
Feng Sun
@nl
Feng Sun
@sl